
The lawsuit alleges Nano-X misled investors about manufacturing efficiency and product demand before disclosing a restructuring at its Korean chip facility, higher cash burn and a fourth-quarter loss that sent the shares down.
Pomerantz LLP said a class action lawsuit has been filed against Nano-X Imaging Ltd. and certain officers on behalf of investors who purchased or otherwise acquired Nano-X securities between March 31, 2025 and April 17, 2026. Investors have until August 11, 2026 to ask the court to appoint them as Lead Plaintiff. The complaint alleges Nano-X overstated efficiency gains in its operations and the level of demand for its products while creating the impression it was successfully scaling manufacturing and production following regulatory approvals and new distribution and supply agreements. According to the filing, the company’s production and manufacturing operations were in fact poorly aligned with demand, driving significantly higher operating expenses and cash burn and increasing the likelihood of disruptive remedial measures, including restructuring and impairment charges. The alleged corrective disclosure came on April 20, 2026, when Nano-X reported fourth-quarter 2025 results showing a net loss of $33.4 million, driven mainly by a $17.5 million charge tied to the impairment of long-lived assets after a restructuring initiative at its Korean chip manufacturing facility. Nano-X said it was shifting to a more efficient outsourced production model better aligned with current and anticipated demand, and also disclosed that then-Chief Financial Officer Ran Daniel would step down effective July 31, 2026. On the related earnings call, Chief Executive Officer Erez Meltzer said the company needed to reduce operating expenses and cash burn at its Korean operation and improve efficiency. Nano-X shares fell $0.695, or 24.39%, to close at $2.155 on April 20.